Barbieri Ricardo Augusto, Kalva-Filho Carlos Augusto, Faria Murilo Henrique, Silveira-Ciola Aline Prieto, Torriani-Pasin Camila, Simieli Lucas, Barbieri Fabio Augusto
Department for Life Quality Studies, University of Bologna (UNIBO), Rimini, Italy.
School of Sciences, Department of Physical Education, Human Movement Research Laboratory (MOVI-LAB), São Paulo State University (Unesp), Bauru, SP, Brazil.
J Hum Kinet. 2024 May 17;93:81-92. doi: 10.5114/jhk/186562. eCollection 2024 Jul.
Aerobic exercise with the correct intensity can attenuate motor and non-motor symptoms of Parkinson's disease (PD) and improve the quality of life. However, a specific, validated, non-invasive, and outside the laboratory protocol that assesses physiological variables to prescribe optimal aerobic exercise intensity for people with PD is nonexistent. Therefore, this study aimed to propose a protocol, the Parkinson's critical heart rate test (Parkinson-CHR test), to determine the critical heart rate (CHR) in individuals with PD and verify its validity, reliability, and sensitivity. Fifteen people with idiopathic PD, who were able to practice exercises, were recruited to participate in the study (71.1 ± 6.6 years). The study consisted of two experiments: i) the first one aimed to assess the validity and reliability of the protocol, with participants performing the test twice at a one-week interval; ii) the second experiment aimed to investigate the protocol sensitivity, with individuals being evaluated before and after an 8-week training program according to Parkinson-CHR intensity. In experiment 1, no differences between test and retest were observed in the time to cover the distances (400, 800 and 1200 m), the total heart rate, the critical heart rate, and critical speed (p > 0.05). In experiment 2, there was a reduction in time to cover 400 and 800 m as well as in the total heart rate for all distances after the 8-week training program. The Parkinson-CHR test is a reliable, reproducible, inexpensive, and non-invasive protocol to assess, prescribe, and monitor aerobic exercise intensity in people with PD.
正确强度的有氧运动可减轻帕金森病（PD）的运动和非运动症状，并改善生活质量。然而，目前尚无一种专门的、经过验证的、非侵入性的且适用于实验室外的方案，用于评估生理变量，从而为帕金森病患者开出最佳有氧运动强度的处方。因此，本研究旨在提出一种方案，即帕金森临界心率测试（Parkinson-CHR测试），以确定帕金森病患者的临界心率（CHR），并验证其有效性、可靠性和敏感性。招募了15名能够进行锻炼的特发性帕金森病患者参与研究（年龄71.1±6.6岁）。该研究包括两个实验：i）第一个实验旨在评估该方案的有效性和可靠性，参与者在一周的间隔内进行两次测试；ii）第二个实验旨在研究该方案的敏感性，根据帕金森-CHR强度，在为期8周的训练计划前后对个体进行评估。在实验1中，在覆盖距离（400米、800米和1200米）的时间、总心率、临界心率和临界速度方面，测试和复测之间未观察到差异（p>0.05）。在实验2中，为期8周的训练计划后，覆盖400米和800米的时间以及所有距离的总心率均有所降低。帕金森-CHR测试是一种可靠、可重复、廉价且非侵入性的方案，用于评估、规定和监测帕金森病患者的有氧运动强度。
